Profile change history

What changed for Tirzepatide?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Tirzepatide identity.

167Total events
165Record additions
2Version changes
5Cited source years

Source-published notices

Research integrity notices

Method and complete cohort →

Before and after

Preserved version changes

Profile updated

Tirzepatide profile

We added search aliases that the cited FDA substance-identity record maps to this active ingredient. The profile's status did not change.

PeptideScanner change date
July 29, 2026
Evidence lane
Profile

Related names

Before
Zepbound
After
Zepbound, Mounjaro

Cited source records

Before
dailymed-tirzepatide-487cd7e7-434c-4925-99fa-aa80b1cc776b-v38, fda-tirzepatide-2023
After
dailymed-tirzepatide-487cd7e7-434c-4925-99fa-aa80b1cc776b-v38, fda-tirzepatide-2023, fda-tirzepatide-identity

Claim citations

Before
name: dailymed-tirzepatide-487cd7e7-434c-4925-99fa-aa80b1cc776b-v38; aliases: dailymed-tirzepatide-487cd7e7-434c-4925-99fa-aa80b1cc776b-v38; category: dailymed-tirzepatide-487cd7e7-434c-4925-99fa-aa80b1cc776b-v38; status: dailymed-tirzepatide-487cd7e7-434c-4925-99fa-aa80b1cc776b-v38; summary: dailymed-tirzepatide-487cd7e7-434c-4925-99fa-aa80b1cc776b-v38, fda-tirzepatide-2023; evidenceNote: dailymed-tirzepatide-487cd7e7-434c-4925-99fa-aa80b1cc776b-v38
After
name: dailymed-tirzepatide-487cd7e7-434c-4925-99fa-aa80b1cc776b-v38; aliases: fda-tirzepatide-identity; category: dailymed-tirzepatide-487cd7e7-434c-4925-99fa-aa80b1cc776b-v38; status: dailymed-tirzepatide-487cd7e7-434c-4925-99fa-aa80b1cc776b-v38; summary: dailymed-tirzepatide-487cd7e7-434c-4925-99fa-aa80b1cc776b-v38, fda-tirzepatide-2023; evidenceNote: dailymed-tirzepatide-487cd7e7-434c-4925-99fa-aa80b1cc776b-v38
Profile updated

Tirzepatide profile

We rewrote the profile summary to describe the cited public record more directly. The cited sources and status did not change.

PeptideScanner change date
July 27, 2026
Evidence lane
Profile

Profile summary

Before
A GIP and GLP-1 receptor agonist represented by an exact current Zepbound label record and an FDA notice.
After
A GIP and GLP-1 receptor agonist. This profile cites a Zepbound label and an FDA notice.

Collection chronology

Evidence added to PeptideScanner

Browse all 165 connected records →

Showing the latest 100 additions by PeptideScanner publication date; the complete connected record set remains available in Latest Research. Most recent addition: August 22, 2026.

Record added

Tirzepatide DailyMed SPL version 12

DailyMed lists Structured Product Labeling version 12 for the reviewed Tirzepatide label family with a published date of 2024-11-04. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
November 4, 2024
Evidence lane
Regulatory
Record added

Tirzepatide DailyMed SPL version 14

DailyMed lists Structured Product Labeling version 14 for the reviewed Tirzepatide label family with a published date of 2024-12-30. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
December 30, 2024
Evidence lane
Regulatory
Record added

Tirzepatide DailyMed SPL version 15

DailyMed lists Structured Product Labeling version 15 for the reviewed Tirzepatide label family with a published date of 2025-01-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
January 6, 2025
Evidence lane
Regulatory
Record added

Tirzepatide DailyMed SPL version 16

DailyMed lists Structured Product Labeling version 16 for the reviewed Tirzepatide label family with a published date of 2025-02-07. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
February 7, 2025
Evidence lane
Regulatory
Record added

Tirzepatide DailyMed SPL version 17

DailyMed lists Structured Product Labeling version 17 for the reviewed Tirzepatide label family with a published date of 2025-02-27. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
February 27, 2025
Evidence lane
Regulatory
Record added

Tirzepatide DailyMed SPL version 18

DailyMed lists Structured Product Labeling version 18 for the reviewed Tirzepatide label family with a published date of 2025-03-21. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
March 21, 2025
Evidence lane
Regulatory
Record added

Tirzepatide DailyMed SPL version 19

DailyMed lists Structured Product Labeling version 19 for the reviewed Tirzepatide label family with a published date of 2025-04-14. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
April 14, 2025
Evidence lane
Regulatory
Record added

Tirzepatide DailyMed SPL version 2

DailyMed lists Structured Product Labeling version 2 for the reviewed Tirzepatide label family with a published date of 2023-11-14. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
November 14, 2023
Evidence lane
Regulatory
Record added

Tirzepatide DailyMed SPL version 21

DailyMed lists Structured Product Labeling version 21 for the reviewed Tirzepatide label family with a published date of 2025-05-05. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
May 5, 2025
Evidence lane
Regulatory
Record added

Tirzepatide DailyMed SPL version 22

DailyMed lists Structured Product Labeling version 22 for the reviewed Tirzepatide label family with a published date of 2025-05-29. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
May 29, 2025
Evidence lane
Regulatory
Record added

Tirzepatide DailyMed SPL version 23

DailyMed lists Structured Product Labeling version 23 for the reviewed Tirzepatide label family with a published date of 2025-07-25. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
July 25, 2025
Evidence lane
Regulatory
Record added

Tirzepatide DailyMed SPL version 28

DailyMed lists Structured Product Labeling version 28 for the reviewed Tirzepatide label family with a published date of 2025-11-17. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
November 17, 2025
Evidence lane
Regulatory
Record added

Tirzepatide DailyMed SPL version 3

DailyMed lists Structured Product Labeling version 3 for the reviewed Tirzepatide label family with a published date of 2023-11-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
November 16, 2023
Evidence lane
Regulatory
Record added

Tirzepatide DailyMed SPL version 30

DailyMed lists Structured Product Labeling version 30 for the reviewed Tirzepatide label family with a published date of 2025-12-31. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
December 31, 2025
Evidence lane
Regulatory
Record added

Tirzepatide DailyMed SPL version 31

DailyMed lists Structured Product Labeling version 31 for the reviewed Tirzepatide label family with a published date of 2026-01-23. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
January 23, 2026
Evidence lane
Regulatory
Record added

Tirzepatide DailyMed SPL version 32

DailyMed lists Structured Product Labeling version 32 for the reviewed Tirzepatide label family with a published date of 2026-02-05. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
February 5, 2026
Evidence lane
Regulatory
Record added

Tirzepatide DailyMed SPL version 36

DailyMed lists Structured Product Labeling version 36 for the reviewed Tirzepatide label family with a published date of 2026-02-26. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
February 26, 2026
Evidence lane
Regulatory
Record added

Tirzepatide DailyMed SPL version 37

DailyMed lists Structured Product Labeling version 37 for the reviewed Tirzepatide label family with a published date of 2026-03-03. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
March 3, 2026
Evidence lane
Regulatory
Record added

Tirzepatide DailyMed SPL version 38

DailyMed lists Structured Product Labeling version 38 for the reviewed Tirzepatide label family with a published date of 2026-05-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
May 6, 2026
Evidence lane
Regulatory
Record added

Tirzepatide DailyMed SPL version 5

DailyMed lists Structured Product Labeling version 5 for the reviewed Tirzepatide label family with a published date of 2024-04-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
April 12, 2024
Evidence lane
Regulatory
Record added

Tirzepatide DailyMed SPL version 8

DailyMed lists Structured Product Labeling version 8 for the reviewed Tirzepatide label family with a published date of 2024-08-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

PeptideScanner change date
August 22, 2026
Cited source date
August 8, 2024
Evidence lane
Regulatory
Record added

Federal Register notice 2022-18523

The Federal Register published notice 2022-18523, attributed to FDA and its parent HHS department, on 2022-08-29. Its official title is “Notice of Approval of Product Under Voucher: Material Threat Medical Countermeasure Priority Review Voucher,” and PeptideScanner's exact reviewed identity mapping connects the document to Tirzepatide.

PeptideScanner change date
August 21, 2026
Cited source date
August 29, 2022
Evidence lane
Regulatory
Record added

Federal Register notice 2023-18026

The Federal Register published notice 2023-18026, attributed to FDA and its parent HHS department, on 2023-08-22. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon and Tirzepatide.

PeptideScanner change date
August 21, 2026
Cited source date
August 22, 2023
Evidence lane
Regulatory
Record added

Federal Register notice 2024-04157

The Federal Register published notice 2024-04157, attributed to FDA and its parent HHS department, on 2024-02-29. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; MOUNJARO,” and PeptideScanner's exact reviewed identity mapping connects the document to Tirzepatide.

PeptideScanner change date
August 21, 2026
Cited source date
February 29, 2024
Evidence lane
Regulatory
Record added

Federal Register notice 2025-20548

The Federal Register published notice 2025-20548, attributed to FDA and its parent HHS department, on 2025-11-21. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon and Tirzepatide.

PeptideScanner change date
August 21, 2026
Cited source date
November 21, 2025
Evidence lane
Regulatory
Record added

Federal Register notice 2025-22131

The Federal Register published notice 2025-22131, attributed to FDA and its parent HHS department, on 2025-12-05. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide, Semaglutide, Teriparatide, Tirzepatide and Vosoritide.

PeptideScanner change date
August 21, 2026
Cited source date
December 5, 2025
Evidence lane
Regulatory
Record added

Federal Register notice 2026-08552

The Federal Register published notice 2026-08552, attributed to FDA and its parent HHS department, on 2026-05-01. Its official title is “List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide, Semaglutide and Tirzepatide.

PeptideScanner change date
August 21, 2026
Cited source date
May 1, 2026
Evidence lane
Regulatory
Record added

Federal Register notice 2026-12937

The Federal Register published notice 2026-12937, attributed to FDA and its parent HHS department, on 2026-06-26. Its official title is “List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Extension of Comment Period,” and PeptideScanner's exact reviewed identity mapping connects the document to Liraglutide, Semaglutide and Tirzepatide.

PeptideScanner change date
August 21, 2026
Cited source date
June 26, 2026
Evidence lane
Regulatory
Record added

Federal Register notice 2026-15285

The Federal Register published notice 2026-15285, attributed to FDA and its parent HHS department, on 2026-07-29. Its official title is “Product-Specific Guidances; Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide, Semaglutide, Teriparatide, Tirzepatide and Vosoritide.

PeptideScanner change date
August 21, 2026
Cited source date
July 29, 2026
Evidence lane
Regulatory
Record added

Tirzepatide and metabolic surgery: complementary approaches for multimodal management of MASLD.

PubMed lists PMID 41258966 in Hepatology international as Letter, Comment, with publication-date metadata of 2025-11-19 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 16, 2026
Cited source date
April 27, 2026
Evidence lane
Literature metadata
Record added

ClinicalTrials.gov record NCT06965413

PeptideScanner retained ClinicalTrials.gov record NCT06965413 at 2026-08-13T05:52:27.007Z. Its registry update date was 2026-08-11, and PeptideScanner's reviewed identity mapping was tirzepatide.

PeptideScanner change date
August 14, 2026
Cited source date
August 11, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07463846

PeptideScanner retained ClinicalTrials.gov record NCT07463846 at 2026-08-13T05:54:14.856Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

PeptideScanner change date
August 14, 2026
Cited source date
August 12, 2026
Evidence lane
Clinical trials
Record added

Real world tirzepatide treatment for fatty liver disease.

PubMed lists PMID 41776028 in Hepatology international as Editorial, with publication-date metadata of 2026-03-03 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 14, 2026
Cited source date
April 27, 2026
Evidence lane
Literature metadata
Record added

Tirzepatide and Autonomic Dysfunction: Insights From Postural Orthostatic Tachycardia Syndrome.

PubMed lists PMID 41945548 in JACC. Case reports as Letter, with publication-date metadata of 2025-12-17 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 14, 2026
Cited source date
August 13, 2026
Evidence lane
Literature metadata
Record added

Facial nodules following filler injections after initiating compounded tirzepatide use.

PubMed lists PMID 42088720 in JAAD case reports as Case Reports, Journal Article, with publication-date metadata of 2026-03-27 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 14, 2026
Cited source date
August 13, 2026
Evidence lane
Literature metadata
Record added

Inflammation-mediated facial nodules to compounded tirzepatide.

PubMed lists PMID 42598502 in JAAD case reports as Letter, with publication-date metadata of 2026-06-17 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 14, 2026
Cited source date
August 14, 2026
Evidence lane
Literature metadata
Record added

ClinicalTrials.gov record NCT06651177

PeptideScanner retained ClinicalTrials.gov record NCT06651177 at 2026-08-13T05:52:27.017Z. Its registry update date was 2026-08-11, and PeptideScanner's reviewed identity mapping was tirzepatide.

PeptideScanner change date
August 13, 2026
Cited source date
August 11, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06727331

PeptideScanner retained ClinicalTrials.gov record NCT06727331 at 2026-08-10T18:10:03.948Z. Its registry update date was 2026-07-09, and PeptideScanner's reviewed identity mapping was tirzepatide.

PeptideScanner change date
August 13, 2026
Cited source date
July 9, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06893211

PeptideScanner retained ClinicalTrials.gov record NCT06893211 at 2026-08-10T18:10:03.966Z. Its registry update date was 2026-07-07, and PeptideScanner's reviewed identity mapping was tirzepatide.

PeptideScanner change date
August 13, 2026
Cited source date
July 7, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06934642

PeptideScanner retained ClinicalTrials.gov record NCT06934642 at 2026-08-10T18:10:03.939Z. Its registry update date was 2026-07-15, and PeptideScanner's reviewed identity mapping was tirzepatide.

PeptideScanner change date
August 13, 2026
Cited source date
July 15, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06935838

PeptideScanner retained ClinicalTrials.gov record NCT06935838 at 2026-08-10T18:10:03.949Z. Its registry update date was 2026-07-08, and PeptideScanner's reviewed identity mapping was tirzepatide.

PeptideScanner change date
August 13, 2026
Cited source date
July 8, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07046819

PeptideScanner retained ClinicalTrials.gov record NCT07046819 at 2026-08-13T05:54:14.859Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

PeptideScanner change date
August 13, 2026
Cited source date
August 12, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07191873

PeptideScanner retained ClinicalTrials.gov record NCT07191873 at 2026-08-10T18:10:04.225Z. Its registry update date was 2026-07-28, and PeptideScanner's reviewed identity mapping was tirzepatide.

PeptideScanner change date
August 13, 2026
Cited source date
July 28, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07257484

PeptideScanner retained ClinicalTrials.gov record NCT07257484 at 2026-08-10T18:10:04.223Z. Its registry update date was 2026-07-22, and PeptideScanner's reviewed identity mapping was tirzepatide.

PeptideScanner change date
August 13, 2026
Cited source date
July 22, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07559500

PeptideScanner retained ClinicalTrials.gov record NCT07559500 at 2026-08-10T18:10:03.920Z. Its registry update date was 2026-07-28, and PeptideScanner's reviewed identity mapping was tirzepatide.

PeptideScanner change date
August 13, 2026
Cited source date
July 28, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07602699

PeptideScanner retained ClinicalTrials.gov record NCT07602699 at 2026-08-10T18:10:03.953Z. Its registry update date was 2026-07-17, and PeptideScanner's reviewed identity mapping was tirzepatide.

PeptideScanner change date
August 13, 2026
Cited source date
July 17, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07693608

PeptideScanner retained ClinicalTrials.gov record NCT07693608 at 2026-08-10T18:10:03.920Z. Its registry update date was 2026-07-09, and PeptideScanner's reviewed identity mapping was tirzepatide.

PeptideScanner change date
August 13, 2026
Cited source date
July 9, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07707778

PeptideScanner retained ClinicalTrials.gov record NCT07707778 at 2026-08-10T18:10:03.948Z. Its registry update date was 2026-07-20, and PeptideScanner's reviewed identity mapping was tirzepatide.

PeptideScanner change date
August 13, 2026
Cited source date
July 20, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07715929

PeptideScanner retained ClinicalTrials.gov record NCT07715929 at 2026-08-10T18:10:04.226Z. Its registry update date was 2026-07-21, and PeptideScanner's reviewed identity mapping was tirzepatide.

PeptideScanner change date
August 13, 2026
Cited source date
July 21, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07734792

PeptideScanner retained ClinicalTrials.gov record NCT07734792 at 2026-08-10T18:10:03.951Z. Its registry update date was 2026-07-29, and PeptideScanner's reviewed identity mapping was tirzepatide.

PeptideScanner change date
August 13, 2026
Cited source date
July 29, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07734870

PeptideScanner retained ClinicalTrials.gov record NCT07734870 at 2026-08-13T05:54:14.859Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

PeptideScanner change date
August 13, 2026
Cited source date
August 12, 2026
Evidence lane
Clinical trials
Record added

Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice.

PubMed lists PMID 38247052 in The Annals of pharmacotherapy as Review, Letter, with publication-date metadata of 2024-01-21 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
July 6, 2026
Evidence lane
Literature metadata
Record added

Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective.

PubMed lists PMID 38717708 in PharmacoEconomics as Journal Article, with publication-date metadata of 2024-05-08 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
July 12, 2026
Evidence lane
Literature metadata
Record added

Can tirzepatide untie the Gordian knot of eating disorders among individuals with type 2 diabetes and obesity?

PubMed lists PMID 39018899 in Journal of diabetes and its complications as Editorial, with publication-date metadata of 2024-07-15 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
July 2, 2026
Evidence lane
Literature metadata
Record added

Treatment Preferences For Comorbid Obesity and Obstructive Sleep Apnea (PRO-CON OSA) Survey: Patient and Provider Preferences for CPAP and/or Tirzepatide.

PubMed lists PMID 41256163 in medRxiv : the preprint server for health sciences as Journal Article, Preprint, with publication-date metadata of 2025-10-05 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
June 26, 2026
Evidence lane
Literature metadata
Record added

Tirzepatide on physical function in adults with overweight or obesity: A systematic review and meta-analysis.

PubMed lists PMID 41705736 in Diabetes, obesity & metabolism as Systematic Review, Journal Article, Meta-Analysis, with publication-date metadata of 2026-02-18 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
July 21, 2026
Evidence lane
Literature metadata
Record added

Early Tirzepatide Use After Acute Myocardial Infarction or Ischemic Stroke in Patients Without Diabetes: A Real-World Propensity-Matched Study.

PubMed lists PMID 41862113 in The American journal of cardiology as Journal Article, with publication-date metadata of 2026-03-19 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
July 11, 2026
Evidence lane
Literature metadata
Record added

Real-World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido-TZP Study.

PubMed lists PMID 41944182 in Diabetes, obesity & metabolism as Journal Article, Multicenter Study, Observational Study, with publication-date metadata of 2026-04-07 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
July 14, 2026
Evidence lane
Literature metadata
Record added

Understanding Weight Regain After Tirzepatide Withdrawal.

PubMed lists PMID 42043833 in JAMA internal medicine as Journal Article, with publication-date metadata of 2026-06-01 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
June 1, 2026
Evidence lane
Literature metadata
Record added

Real-Life Data of Tirzepatide Use to Support Lifestyle Modification in Patients with Metabolic Syndrome.

PubMed lists PMID 42075085 in Nutrients as Journal Article, with publication-date metadata of 2026-04-17 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
July 16, 2026
Evidence lane
Literature metadata
Record added

Shifts in waist-to-height ratio categories within tirzepatide groups: a post-hoc analysis of SURMOUNT-1.

PubMed lists PMID 42082865 in Journal of endocrinological investigation as Journal Article, Randomized Controlled Trial, Clinical Trial, Phase III, with publication-date metadata of 2026-05-04 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
July 16, 2026
Evidence lane
Literature metadata
Record added

GLP-1/GIP dual agonist tirzepatide in obstructive sleep apnea syndrome: mechanisms, evidence, and clinical perspectives.

PubMed lists PMID 42136855 in Frontiers in medicine as Journal Article, Review, with publication-date metadata of 2026-04-29 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
May 15, 2026
Evidence lane
Literature metadata
Record added

Correction: Treatment preferences for comorbid obesity and obstructive sleep apnea (PRO-CON OSA) survey: Patient and provider preferences for CPAP and/or tirzepatide.

PubMed lists PMID 42151574 in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine as Published Erratum, with publication-date metadata of 2026-05-18 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
June 26, 2026
Evidence lane
Literature metadata
Record added

Early cardiovascular-kidney-metabolic progression with tirzepatide: population definition and clinical interpretation.

PubMed lists PMID 42155604 in Diabetes research and clinical practice as Letter, with publication-date metadata of 2026-05-19 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
June 6, 2026
Evidence lane
Literature metadata
Record added

On the Noninferiority of Tirzepatide: Insights From SURPASS-CVOT.

PubMed lists PMID 42233554 in Journal of the American College of Cardiology as Journal Article, with publication-date metadata of 2026-06-02 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
June 3, 2026
Evidence lane
Literature metadata
Record added

Residual gastric content after tirzepatide discontinuation: is one week enough?

PubMed lists PMID 42329593 in Minerva anestesiologica as Journal Article, with publication-date metadata of 2026-06-22 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
June 22, 2026
Evidence lane
Literature metadata
Record added

Experience with Tirzepatide and Weight Management During and After a Clinical Trial in Japanese Patients with Obesity Disease: A Qualitative Study.

PubMed lists PMID 42334799 in Advances in therapy as Journal Article, with publication-date metadata of 2026-06-23 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
June 23, 2026
Evidence lane
Literature metadata
Record added

Can the NHS afford Mounjaro? It spent £574m on the jab last year despite most eligible patients not getting it.

PubMed lists PMID 42373101 in BMJ (Clinical research ed.) as Journal Article, with publication-date metadata of 2026-06-28 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
June 29, 2026
Evidence lane
Literature metadata
Record added

Correction: Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review.

PubMed lists PMID 42388932 in Cureus as Published Erratum, Journal Article, with publication-date metadata of 2026-06-30 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
August 13, 2026
Cited source date
July 6, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 37989596

PeptideScanner retained PubMed bibliographic metadata for PMID 37989596 at 2026-08-10T10:49:06.851Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2023-11-21. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 30, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 40036855

PeptideScanner retained PubMed bibliographic metadata for PMID 40036855 at 2026-08-10T10:49:06.932Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2025-03-04. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
August 2, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 40383978

PeptideScanner retained PubMed bibliographic metadata for PMID 40383978 at 2026-08-10T10:49:06.944Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2025-05-19. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
August 1, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 40510020

PeptideScanner retained PubMed bibliographic metadata for PMID 40510020 at 2026-08-10T10:49:06.950Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2025-06-13. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
August 2, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41032183

PeptideScanner retained PubMed bibliographic metadata for PMID 41032183 at 2026-08-10T10:49:06.970Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2025-10-01. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 30, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41077767

PeptideScanner retained PubMed bibliographic metadata for PMID 41077767 at 2026-08-10T10:49:06.977Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2025-10-13. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
August 2, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41540105

PeptideScanner retained PubMed bibliographic metadata for PMID 41540105 at 2026-08-10T18:13:40.558Z. PubMed recorded a metadata revision date of 2026-07-27 and an Entrez history date of 2026-01-15. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 27, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41917519

PeptideScanner retained PubMed bibliographic metadata for PMID 41917519 at 2026-08-10T10:49:08.829Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-04-01. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 30, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41962807

PeptideScanner retained PubMed bibliographic metadata for PMID 41962807 at 2026-08-10T18:13:46.844Z. PubMed recorded a metadata revision date of 2026-07-27 and an Entrez history date of 2026-04-10. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 27, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42260100

PeptideScanner retained PubMed bibliographic metadata for PMID 42260100 at 2026-08-10T18:13:52.233Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-08. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 26, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42307617

PeptideScanner retained PubMed bibliographic metadata for PMID 42307617 at 2026-08-10T18:13:52.282Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-17. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 26, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42464179

PeptideScanner retained PubMed bibliographic metadata for PMID 42464179 at 2026-08-10T18:13:55.290Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-07-17. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 26, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42487213

PeptideScanner retained PubMed bibliographic metadata for PMID 42487213 at 2026-08-10T10:49:10.780Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-23. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 30, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42507846

PeptideScanner retained PubMed bibliographic metadata for PMID 42507846 at 2026-08-10T18:13:56.762Z. PubMed recorded a metadata revision date of 2026-07-27 and an Entrez history date of 2026-07-27. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 27, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42516860

PeptideScanner retained PubMed bibliographic metadata for PMID 42516860 at 2026-08-10T18:13:56.767Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 29, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42518363

PeptideScanner retained PubMed bibliographic metadata for PMID 42518363 at 2026-08-10T18:13:56.773Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 29, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42518535

PeptideScanner retained PubMed bibliographic metadata for PMID 42518535 at 2026-08-10T18:13:56.774Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 29, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42521631

PeptideScanner retained PubMed bibliographic metadata for PMID 42521631 at 2026-08-10T18:13:56.781Z. PubMed recorded a metadata revision date of 2026-07-28 and an Entrez history date of 2026-07-28. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 28, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42524366

PeptideScanner retained PubMed bibliographic metadata for PMID 42524366 at 2026-08-10T18:13:56.785Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-29. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 29, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42526939

PeptideScanner retained PubMed bibliographic metadata for PMID 42526939 at 2026-08-10T18:13:57.051Z. PubMed recorded a metadata revision date of 2026-07-29 and an Entrez history date of 2026-07-29. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 29, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42530904

PeptideScanner retained PubMed bibliographic metadata for PMID 42530904 at 2026-08-10T10:49:12.922Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-30. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 30, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42531456

PeptideScanner retained PubMed bibliographic metadata for PMID 42531456 at 2026-08-10T10:49:12.922Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2026-07-30. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
July 30, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42542297

PeptideScanner retained PubMed bibliographic metadata for PMID 42542297 at 2026-08-10T10:49:12.964Z. PubMed recorded a metadata revision date of 2026-08-01 and an Entrez history date of 2026-08-01. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 12, 2026
Cited source date
August 1, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41802735

PeptideScanner retained PubMed bibliographic metadata for PMID 41802735 at 2026-08-10T10:49:08.786Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-03-09. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 11, 2026
Cited source date
August 5, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 41804540

PeptideScanner retained PubMed bibliographic metadata for PMID 41804540 at 2026-08-10T10:49:08.787Z. PubMed recorded a metadata revision date of 2026-08-06 and an Entrez history date of 2026-03-10. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 11, 2026
Cited source date
August 6, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42012431

PeptideScanner retained PubMed bibliographic metadata for PMID 42012431 at 2026-08-10T10:49:08.852Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-04-21. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 11, 2026
Cited source date
August 3, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42275945

PeptideScanner retained PubMed bibliographic metadata for PMID 42275945 at 2026-08-10T10:49:10.676Z. PubMed recorded a metadata revision date of 2026-08-05 and an Entrez history date of 2026-06-11. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 11, 2026
Cited source date
August 5, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42289805

PeptideScanner retained PubMed bibliographic metadata for PMID 42289805 at 2026-08-10T10:49:10.680Z. PubMed recorded a metadata revision date of 2026-08-03 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 11, 2026
Cited source date
August 3, 2026
Evidence lane
Literature metadata
Record added

PubMed record PMID 42532547

PeptideScanner retained PubMed bibliographic metadata for PMID 42532547 at 2026-08-10T10:49:12.924Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2026-07-30. PeptideScanner associated this retained record with the identity slug tirzepatide. These dates describe PubMed metadata history, not the article's original publication date.

PeptideScanner change date
August 11, 2026
Cited source date
August 2, 2026
Evidence lane
Literature metadata